Thus, deletion of CerS2, either systemically or selectively in the pancreatic β-cell, to limit the production of very long ceramide chains, lowers the insulin content of pancreatic islets and impairs glucose intolerance on both normal and high fat diet [17–20]. The gene discussed is INS; the disease is Glucose intolerance.